We are live on ! Find out more
VCM

Vigilant Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+15.33%
3 Year Est. Return
+48.75%
5 Year Est. Return
+353.4%
10 Year Est. Return
+645.13%
AUM
$1.24B
AUM Growth
+$112M
Cap. Flow
+$32.7M
Cap. Flow %
2.64%
Top 10 Hldgs %
29.94%
Holding
452
New
96
Increased
129
Reduced
64
Closed
14

Top Buys

Rank Stock Value
1
BKR icon
Baker Hughes
BKR
+$15.8M
2
EAF icon
GrafTech
EAF
+$7.81M
3
ABT icon
Abbott
ABT
+$2.22M
4
UNP icon
Union Pacific
UNP
+$2.04M
5
NKE icon
Nike
NKE
+$1.08M

Sector Composition

Rank Sector Weight
1 Technology 19.99%
2 Healthcare 15.23%
3 Financials 11.33%
4 Consumer Discretionary 10.61%
5 Industrials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
26
Waste Management
WM
$92.4B
$22.4M 1.81%
159,964
-622
-0.4% -$86K
AZN icon
27
AstraZeneca
AZN
$251B
$22.3M 1.8%
186,264
+2,395
+1% +$263K
ARE icon
28
Alexandria Real Estate Equities
ARE
$8.41B
$21.4M 1.73%
117,573
+3,691
+3% +$661K
STZ icon
29
Constellation Brands
STZ
$23.1B
$21.4M 1.73%
91,354
+1,034
+1% +$243K
LHX icon
30
L3Harris
LHX
$53B
$21.2M 1.72%
98,306
+1,120
+1% +$241K
AWK icon
31
American Water Works
AWK
$26.9B
$20.7M 1.67%
134,050
+640
+0.5% +$99.7K
GS icon
32
Goldman Sachs
GS
$302B
$20.1M 1.62%
52,877
+2,844
+6% +$1.02M
TTE icon
33
TotalEnergies
TTE
$190B
$19.9M 1.61%
440,107
+9,292
+2% +$435K
ALLE icon
34
Allegion
ALLE
$14.5B
$19.8M 1.6%
142,463
-1,667
-1% -$228K
GPN icon
35
Global Payments
GPN
$23.3B
$19.6M 1.59%
104,566
+3,355
+3% +$675K
CB icon
36
Chubb
CB
$136B
$19.5M 1.58%
122,751
-655
-0.5% -$109K
CAG icon
37
Conagra Brands
CAG
$7.17B
$19.3M 1.56%
529,204
+17,606
+3% +$659K
ECL icon
38
Ecolab
ECL
$80.5B
$18.5M 1.5%
89,819
+3,390
+4% +$737K
CHD icon
39
Church & Dwight Co
CHD
$24.5B
$18.5M 1.49%
216,772
+3,888
+2% +$336K
BKR icon
40
Baker Hughes
BKR
$61.9B
$15.7M 1.27%
+686,550
New +$15.8M
ISRG icon
41
Intuitive Surgical
ISRG
$134B
$14M 1.13%
45,693
-1,383
-3% -$388K
CTLT
42
DELISTED
CATALENT, INC.
CTLT
$13.9M 1.12%
128,617
-4,021
-3% -$431K
ILMN icon
43
Illumina
ILMN
$28.6B
$13.3M 1.07%
28,784
+472
+2% +$190K
TXG icon
44
10x Genomics
TXG
$5.84B
$12.1M 0.98%
62,027
+4,437
+8% +$803K
BR icon
45
Broadridge
BR
$19B
$12M 0.97%
74,399
+737
+1% +$118K
GLD icon
46
SPDR Gold Trust
GLD
$141B
$9.05M 0.73%
54,661
-630
-1% -$107K
EAF icon
47
GrafTech
EAF
$202M
$7.23M 0.58%
+62,256
New +$7.81M
PFE icon
48
Pfizer
PFE
$150B
$3.47M 0.28%
88,568
+1,202
+1% +$46.7K
PG icon
49
Procter & Gamble
PG
$338B
$3.1M 0.25%
22,972
+508
+2% +$68.7K
AME icon
50
Ametek
AME
$57.9B
$2.6M 0.21%
19,460

Similar funds

Vigilant Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Vigilant Capital Management held 452 positions worth $1.24B, up 10% from $1.12B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Vigilant Capital Management's Q2 2021 filing shows 96 new, 129 increased, 64 reduced and 14 closed positions. Its largest new stake was Baker Hughes: 686,550 shares worth $15.7M. The largest sale was Alexion Pharmaceuticals, an estimated $4.51M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Vigilant Capital Management's largest Q2 2021 buy was Baker Hughes: 686,550 shares worth $15.7M.
  • Vigilant Capital Management added most to Abbott in Q2 2021, an estimated $2.22M increase.
  • Vigilant Capital Management's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $4.51M.
  • Vigilant Capital Management fully exited Schwab US Mid-Cap ETF in Q2 2021, selling an estimated $25K.
  • Vigilant Capital Management's ten largest holdings make up 30% of its $1.24B portfolio in Q2 2021.
  • Vigilant Capital Management opened 96 new positions and closed 14 in Q2 2021.
  • Vigilant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.24B.

Based on Vigilant Capital Management's 13F filing for Q2 2021, filed 9 Jul 2021.